Latest News and Press Releases
Want to stay updated on the latest news?
-
To suspend trading of these financial instruments on 20-06-2008 (orders placed in the Order Book prior to the trading halt (suspension) will be cancelled) : Gubernija ORS (LT0000114357 GUB1L)...
-
BASF SE / Miscellaneous 20.06.2008 Release of a UK Regulatory Announcement, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this...
-
BASF SE / Miscellaneous 20.06.2008 Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this...
-
To the shareholders of Pharmexa A/S Pursuant to article 7 of the articles of association the shareholders of Pharmexa A/S are hereby con-vened to an extraordinary general meeting on...
-
Please see the attached articles of association of Genmab A/S dated June 4, 2008. ...
-
Today, on June 20, Agrowill Group AB signed the share purchase agreement regarding acquisition of 97,28 percent of Grūduva UAB. Agrowill Group AB will pay LTL 34,5 million (EUR 9,99...
-
Notification on transactions concluded by manager of the company ...
-
Read more in today's press release from The Lancet: "New Oral Drug Laquinimod Reduces Multiple Sclerosis Disease Activity and is Safe and Well Tolerated" on www.thelancet.com. Lund,...
-
Active Biotechs orala MS-läkemedel laquinimod presenteras i den vetenskapliga tidskriften The Lancet
För ytterligare information, läs dagens pressmeddelande från The Lancet: "New Oral Drug Laquinimod Reduces Multiple Sclerosis Disease Activity and is Safe and Well Tolerated" på...
-
Active Biotechs orala MS-läkemedel laquinimod presenteras i den vetenskapliga tidskriften The LancetI morgondagens utgåva av den vetenskapliga tidskriften The Lancet, Volym 371, nummer 9630, publiceras en artikel som behandlar Active Biotechs (OMX Nordic: ACTI) och Teva Pharmaceutical Industries...